古古甾酮对甲状腺眼病眼眶成纤维细胞的治疗作用
本研究利用甲状腺眼病(GO)患者及非GO对照的原代眼眶成纤维细胞,观察古古甾酮(GS)对IL-1β诱导的炎症因子、透明质酸生成及脂肪分化的影响。结果显示GS呈剂量依赖性抑制IL-6、IL-8、MCP-1、COX-2及透明质酸,并减少脂滴形成和PPARγ、C/EBPα/β、SREBP-1表达,同时减弱NF-κB磷酸化。这是GS治疗GO的首次体外临床前证据。
要点
- GS剂量依赖性抑制GO眼眶成纤维细胞中IL-1β诱导的炎症因子和透明质酸生成。
- GS剂量依赖性减少脂肪分化及PPARγ、C/EBPα/β、SREBP-1表达。
- GS预处理减弱IL-1β诱导的NF-κB磷酸化,提示抗炎机制。
核心结论
- GS对GO眼眶成纤维细胞的炎症、透明质酸生成和脂肪分化具有显著抑制作用,为首个体外临床前证据。
研究设计与样本
- 使用GO患者和非GO对照的原代眼眶成纤维细胞培养,检测GS对IL-1β诱导的炎症因子、透明质酸及脂肪分化的影响。
主要发现
- 非细胞毒性浓度GS剂量依赖性抑制IL-1β诱导的IL-6、IL-8、MCP-1和COX-2的mRNA及蛋白水平。
- GS显著抑制透明质酸水平。
- GS剂量依赖性减少脂滴形成及PPARγ、C/EBPα/β、SREBP-1蛋白表达。
- GS预处理减弱IL-1β诱导的NF-κB磷酸化。
临床怎么用
- GS可能作为GO抗炎、抗透明质酸生成及抗脂肪分化的潜在治疗药物,但需进一步体内及临床研究验证。
局限性
- 研究为体外临床前实验,样本量及具体数值未在摘要中报告,需结合全文评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Inflammation, hyaluronan production, and adipogenesis are the main pathological events leading to Graves' orbitopathy (GO). Guggulsterone (GS), a phytosterol found in the resin of the guggul plant, is a well-known treatment for several inflammatory disorders, such as arthritis, obesity, and hyperlipidemia. Here we investigated the effects of GS treatment on GO pathology. METHODS: Using primary cultures of orbital fibroblasts from GO patients and non-GO controls, we examined the effects of GS on hyaluronan production and the production of proinflammatory cytokines induced by interleukin (IL)-1β, using real-time reverse transcription-polymerase chain reaction analysis, western blots, and enzyme-linked immunosorbent assays. Further, adipogenic differentiation was evaluated by quantification of Oil Red O staining and assessment of protein levels of peroxisome proliferator activator gamma (PPARγ), CCAAT-enhancer-binding proteins (C/EBP) α and β, and sterol regulatory element-binding protein-1 (SREBP-1). RESULTS: Treatment with noncytotoxic concentrations of GS resulted in the dose-dependent inhibition of IL-1β-induced inflammatory cytokines, including IL-6, IL-8, MCP-1, and COX-2, at both mRNA and protein levels. The hyaluronan level was also significantly suppressed by GS. Moreover, GS significantly decreased the formation of lipid droplets and expression of PPARγ, C/EBP α/β, and SREBP-1 in a dose-dependent manner. GS pretreatment attenuated the phosphorylation of nuclear factor-kappa B induced by IL-1β. CONCLUSIONS: Our data show significant inhibitory effects of GS on inflammation, production of hyaluronan, and adipogenesis in orbital fibroblasts. To our knowledge, this is the first in vitro preclinical evidence of the therapeutic effect of GS in GO.
引用
- Kim BR, Kim J, Lee JE, et al. Therapeutic Effect of Guggulsterone in Primary Cultured Orbital Fibroblasts Obtained From Patients with Graves' Orbitopathy. Invest Ophthalmol Vis Sci. 2020. PMID: 32196098. doi:10.1167/iovs.61.3.39
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。